Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-26-041483
Filing Date
2026-04-09
Accepted
2026-04-09 16:01:19
Documents
16
Period of Report
2026-05-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A pmn-20260520xdef14a.htm   iXBRL DEF 14A 922337
2 GRAPHIC pmn-20260520xdef14a_a001.jpg GRAPHIC 27602
3 GRAPHIC pmn-20260520xdef14a_a008.jpg GRAPHIC 34812
4 GRAPHIC pmn-20260520xdef14a_bg001.jpg GRAPHIC 111765
5 GRAPHIC pmn-20260520xdef14a_bg002.jpg GRAPHIC 142937
  Complete submission text file 0001104659-26-041483.txt   2007903

Data Files

Seq Description Document Type Size
6 EX-101.SCH pmn-20260520.xsd EX-101.SCH 3045
7 EX-101.LAB pmn-20260520_lab.xml EX-101.LAB 3683
8 EX-101.PRE pmn-20260520_pre.xml EX-101.PRE 3118
19 EXTRACTED XBRL INSTANCE DOCUMENT pmn-20260520xdef14a_htm.xml XML 1592
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41429 | Film No.: 26851521
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)